Logo Image
News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Videos

Treatment Burden

July 20th 2020

Improved Durability

July 20th 2020

Treating the Whole Patient: When to Switch (and Why)

July 20th 2020

Real-World Experiences and Clinical Trials: Why Outcomes Differ

July 20th 2020

Treatment Strategies During a Pandemic

July 20th 2020

The Advent of the Anti-Vascular Endothelial Growth Factor (VEGF) Treatment Regimen

July 20th 2020

Intro

July 20th 2020
Chuck Hess

ASRS 2019 Street Team: Chuck Hess

ByOT Staff Reports
September 4th 2019

Clinical Trials in the COVID-19 Era

July 18th 2019

Telemedicine

July 18th 2019

Artificial Intelligence (AI) and Retina

July 18th 2019

Coming Down the Pike

July 18th 2019

Treatment Burden

July 18th 2019

Improved Durability

July 18th 2019

Treating the Whole Patient: When to Switch (and Why)

July 18th 2019

Real-World Experiences and Clinical Trials: Why Outcomes Differ

July 18th 2019

Treatment Strategies During a Pandemic

July 18th 2019

Intro

July 18th 2019
  • Prev
  • 1
  • More pages
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Prev
Advertisement
Advertisement

Trending on Modern Retina

1

Q&A: Using natural images for the evaluation of distance image quality in IOLs

2

Our humble genome

3

UveAI: Automated fluorescein angiography scoring for retinal inflammation in uveitis

4

Q&A: Evaluating 24-month outcomes with Abiliti 1-Day in pediatric myopia control

5

FDA grants appeal for bevacizumab-vikg BLA in neovascular AMD

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us